July 10, 2020

Volume X, Number 192

July 09, 2020

Subscribe to Latest Legal News and Analysis

July 08, 2020

Subscribe to Latest Legal News and Analysis

July 07, 2020

Subscribe to Latest Legal News and Analysis

Pets and Vets: Therapeutic Vet Diet Compliance Policy Guide Finalized

FDA finalizes enforcement policy with respect to therapeutic veterinary diets.

  • As a general matter, companies may not make therapeutic or “drug” claims in connection with the marketing of food or feed, including pet food.  However, in reality, therapeutic pet food products have been marketed for years without official drug approvals in accordance with FDA’s longstanding enforcement discretion policy in this space.  In 2012, FDA issued a draft Compliance Policy Guide (CPG) explaining the criteria that the Agency would consider when determining whether to take enforcement action regarding dog and cat food diets intended to treat specific diseases.  FDA generally has exercised enforcement discretion with respect to “drug requirements” for therapeutic pet food products where: (1) the product provided all or most nutrients in support of an animal’s total required daily nutrient needs; (2) labels and marketing materials made available to the general public did not contain claims to treat or prevent disease; and (3) the products were distributed only through licensed veterinarians.

  • In April 2016, FDA issued a final version of its CPG on therapeutic veterinary diets.  Consistent with the draft CPG, the final version confirms FDA’s view that although therapeutic veterinary diets technically are “drugs” under the law, the Agency is “less likely” to initiate enforcement action when 11 specific criteria are met (e.g., marketing solely through licensed veterinary channels, the manufacturer’s compliance with food regulatory requirements, and avoidance of “drug claims” directly on the product label, among others).

  • Although the CPG provides a list of regulatory and marketing conditions that may diminish the risk of FDA enforcement action within this highly specialized market, the policy provides no exceptions to the requirement that ingredients in therapeutic veterinary diets be approved food additives, generally recognized as safe (GRAS), or listed in the Official Publication of the Association of American Feed Control Officials (AAFCO Manual).  In this manner, although the CPG may provide manufacturers in this space with some flexibility related to the “drug” requirements, companies still must comply with the “food” requirements to market therapeutic veterinary diets.

© 2020 Keller and Heckman LLPNational Law Review, Volume VI, Number 124


About this Author

Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition...